Palandri et al.ruxolitinibmomelotinibfedratinibMPNmyelofibrosisPhiladelphia-negative chronic myeloproliferative neoplasms
… drug survival was higher than that reported in the literature (Palandri et al.).Conflict of Interest No conflict of interest…
1articles mentioning institutions
1institution mentions
1distinct institutions extracted
0%of mentions human-reviewed
Active filtersEntity: Palandri et al. ×
Palandri et al.
This institution is selected. Its supporting articles are shown below.